Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News MHRA approves OTC sale of naproxen

MHRA approves OTC sale of naproxen

3rd April 2008

The Medicines and Healthcare products Regulatory Authority (MHRA) has approved the sale of naproxen tablets over the counter (OTC) of pharmacies.

Currently, the drug – used to relieve period pain – is only available through prescription but from April 14th it will be more easily available.

The MHRA highlighted estimates which suggest between 40 and 70 per cent of women suffer from pain during their menstrual cycles, while as many as ten per cent find the pain can interfere with their daily activities.

Before it recommended the approval, the Commission on Human Medicines considered the non-steroidal anti-inflammatory drug and concluded that for such women the benefits outweigh the risks.

Dr June Raine, director of vigilance and risk management of medicines at the MHRA, spoke positively of the move.

“Period pain is a condition which can be successfully managed by women themselves. OTC naproxen will expand the choice of treatments available for this common condition from pharmacies,” she said.

Recently the MHRA issued advice to parents of babies and toddlers, suggesting that certain OTC cough medicines were unsafe for children under the age of two.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.